Fate Therapeutics (FATE) EBT Margin (2016 - 2025)
Historic EBT Margin for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to 1847.21%.
- Fate Therapeutics' EBT Margin fell 2877200.0% to 1847.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 2270.21%, marking a year-over-year decrease of 9407300.0%. This contributed to the annual value of 1415.8% for FY2024, which is 11429900.0% down from last year.
- Per Fate Therapeutics' latest filing, its EBT Margin stood at 1847.21% for Q3 2025, which was down 2877200.0% from 1785.37% recorded in Q2 2025.
- Fate Therapeutics' 5-year EBT Margin high stood at 42.21% for Q1 2023, and its period low was 6236.23% during Q2 2023.
- Its 5-year average for EBT Margin is 1475.7%, with a median of 594.45% in 2024.
- Its EBT Margin has fluctuated over the past 5 years, first crashed by -57922600bps in 2023, then skyrocketed by 56417800bps in 2024.
- Over the past 5 years, Fate Therapeutics' EBT Margin (Quarter) stood at 404.74% in 2021, then surged by 66bps to 138.74% in 2022, then plummeted by -1778bps to 2605.07% in 2023, then dropped by -19bps to 3111.51% in 2024, then surged by 41bps to 1847.21% in 2025.
- Its last three reported values are 1847.21% in Q3 2025, 1785.37% for Q2 2025, and 2329.28% during Q1 2025.